Long-term outcomes and cost-effectiveness of a magnet-based valve voice prosthesis for endoprosthesis leakage treatment
- 26 February 2022
- journal article
- research article
- Published by Springer Nature in European Archives of Oto-Rhino-Laryngology
- Vol. 279 (8) , 4167-4172
Abstract
Purpose Tracheoesophageal speech is considered the gold standard for rehabilitation following total laryngectomy. The main reason of voice prosthesis failure is the endoprosthesis leakage. Provox ActiValve® incorporates a magnet-based valve system to achieve active closure of the valve to treat these leakages, with the drawback of being significantly more expensive. The aim of the study was to compare the Provox Vega® and Provox ActiValve® duration and costs in patients with replacements increase due to endoprosthetic leakage. Methods Prospective case-crossover study in laryngectomized patients with Provox Vega® and endoprosthesis leakage to whom a Provox ActiValve® was placed. Survival and possible factors that affect voice prosthesis were studied using Kaplan–Meier curves and Cox Proportional Hazards Regression. Cost-effectiveness analysis from the perspective of the Spanish Public National Health System with incremental cost-effectiveness calculation was performed. Results A total of 159 prostheses were evaluated. The most frequent reason for replacement was the endoprosthesis leakage (N = 129; 83.77%) in both models. The mean duration-time of Provox Vega® was 44.77 ± 2.82 days (CI 95%, 39.18–50.35; median 36 days), and 317.34 ± 116.8 days (CI 95% 86.66–548; median 286 days) for the Provox ActiValve® (p < 0.000). For every replacement not made thanks to the Provox ActiValve® there was saving of 133.97€ Conclusions The Provox ActiValve® is a cost-effective solution in patients with increased prosthesis replacements due to endoprosthetic leakage, reducing the number of changes and cost compared to Provox Vega®.Keywords
This publication has 21 references indexed in Scilit:
- The development and treatment of periprosthetic leakage after prosthetic voice restoration. A literature review and personal experience part I: the development of periprosthetic leakageEuropean Archives of Oto-Rhino-Laryngology, 2014
- Are modern voice prostheses better? A lifetime comparison of 749 voice prosthesesEuropean Archives of Oto-Rhino-Laryngology, 2013
- Die Kosten für verschiedene Stimmprothesenmodelle in Abhängigkeit der durchschnittlichen LiegezeitLaryngo-Rhino-Otologie, 2013
- Multivariable analysis of risk factors for enlargement of the tracheoesophageal puncture after total laryngectomyHead & Neck, 2011
- Determining the efficacy and cost‐effectiveness of the activalve: Results of a long‐term prospective trialThe Laryngoscope, 2011
- Enlarged tracheoesophageal puncture after total laryngectomy: A systematic review and meta‐analysisHead & Neck, 2011
- Long‐Term Results of Provox ActiValve, Solving the Problem of Frequent Candida‐ and “Underpressure”‐Related Voice Prosthesis ReplacementsThe Laryngoscope, 2008
- Análisis coste-efectividad en la evaluación económica de intervenciones sanitariasMedicina Clinica, 2004
- Should We Use a Case-Crossover Design?Annual Review of Public Health, 2000
- Cost utility analysis: What should be measured?Social Science & Medicine, 1994